APA (7th ed.) Citation

Schiffenbauer, A., Garg, M., Castro, C., Pokrovnichka, A., Joe, G., Shrader, J., . . . Gourley, M. (2018). A randomized, double-blind, placebo-controlled trial of infliximab in refractory polymyositis and dermatomyositis. Seminars in arthritis and rheumatism, 47(6), 858-864. https://doi.org/10.1016/j.semarthrit.2017.10.010

Chicago Style (17th ed.) Citation

Schiffenbauer, Adam, et al. "A Randomized, Double-blind, Placebo-controlled Trial of Infliximab in Refractory Polymyositis and Dermatomyositis." Seminars in Arthritis and Rheumatism 47, no. 6 (2018): 858-864. https://doi.org/10.1016/j.semarthrit.2017.10.010.

MLA (9th ed.) Citation

Schiffenbauer, Adam, et al. "A Randomized, Double-blind, Placebo-controlled Trial of Infliximab in Refractory Polymyositis and Dermatomyositis." Seminars in Arthritis and Rheumatism, vol. 47, no. 6, 2018, pp. 858-864, https://doi.org/10.1016/j.semarthrit.2017.10.010.